An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Removal
According to the social media company, the service has taken down problematic material and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.
Digital Trading Activities
Research also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at residence.
After moments of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.
Item Details and Pricing
Within these groups, messages display black plastic packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for the messaging service said it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has already seen patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant medical dangers”.
